258 related articles for article (PubMed ID: 21502063)
1. Application of Quality by Design (QbD) Principles to Extractables/Leachables Assessment. Establishing a Design Space for Terminally Sterilized Aqueous Drug Products Stored in a Plastic Packaging System.
Jenke D
PDA J Pharm Sci Technol; 2010; 64(6):527-35. PubMed ID: 21502063
[TBL] [Abstract][Full Text] [Related]
2. Simulated Leaching (Migration) Study for a Model Container-Closure System Applicable to Parenteral and Ophthalmic Drug Products.
Jenke D; Egert T; Hendricker A; Castner J; Feinberg T; Houston C; Hunt DG; Lynch M; Nicholas K; Norwood DL; Paskiet D; Ruberto M; Smith EJ; Holcomb F; Markovic I
PDA J Pharm Sci Technol; 2017; 71(2):68-87. PubMed ID: 27974627
[TBL] [Abstract][Full Text] [Related]
3. A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.
Jenke D; Carlson T
PDA J Pharm Sci Technol; 2014; 68(5):407-55. PubMed ID: 25336416
[TBL] [Abstract][Full Text] [Related]
4. A Safety Risk-Based Extractables and/or Leachables Qualification Strategy for Packaged Drug Products.
Jenke D
PDA J Pharm Sci Technol; 2021; 75(6):506-535. PubMed ID: 33990423
[TBL] [Abstract][Full Text] [Related]
5. Application of Arrhenius Kinetics to Acceleration of Controlled Extraction Studies.
Jenke D
PDA J Pharm Sci Technol; 2019; 73(2):135-169. PubMed ID: 30361282
[TBL] [Abstract][Full Text] [Related]
6. Materials in Manufacturing and Packaging Systems as Sources of Elemental Impurities in Packaged Drug Products: A Literature Review.
Jenke DR; Stults CL; Paskiet DM; Ball DJ; Nagao LM
PDA J Pharm Sci Technol; 2015 1/2; 69(1):1-48. PubMed ID: 25691713
[TBL] [Abstract][Full Text] [Related]
7. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
[TBL] [Abstract][Full Text] [Related]
8. Proper Accounting for Surface Area to Solution Volume Ratios in Exaggerated Extractions.
Jenke DR; Rabinow BE
PDA J Pharm Sci Technol; 2017; 71(3):225-233. PubMed ID: 28196915
[TBL] [Abstract][Full Text] [Related]
9. The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP).
Paskiet D; Jenke D; Ball D; Houston C; Norwood DL; Markovic I
PDA J Pharm Sci Technol; 2013; 67(5):430-47. PubMed ID: 24084659
[TBL] [Abstract][Full Text] [Related]
10. Development and Justification of a Risk Evaluation Matrix To Guide Chemical Testing Necessary To Select and Qualify Plastic Components Used in Production Systems for Pharmaceutical Products.
Jenke D
PDA J Pharm Sci Technol; 2015; 69(6):677-712. PubMed ID: 26659101
[TBL] [Abstract][Full Text] [Related]
11. A general assessment of the physiochemical factors that influence leachables accumulation in pharmaceutical drug products and related solutions.
Jenke D
PDA J Pharm Sci Technol; 2011; 65(2):166-76. PubMed ID: 21502076
[TBL] [Abstract][Full Text] [Related]
12. Extractables characterization for five materials of construction representative of packaging systems used for parenteral and ophthalmic drug products.
Jenke D; Castner J; Egert T; Feinberg T; Hendricker A; Houston C; Hunt DG; Lynch M; Shaw A; Nicholas K; Norwood DL; Paskiet D; Ruberto M; Smith EJ; Holcomb F
PDA J Pharm Sci Technol; 2013; 67(5):448-511. PubMed ID: 24084660
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on the PQRI Extractables and Leachables "Safety Thresholds and Best Practices" Recommendations for Inhalation Drug Products.
Norwood DL; Nagao LM; Stults CL
PDA J Pharm Sci Technol; 2013; 67(5):413-29. PubMed ID: 24084658
[TBL] [Abstract][Full Text] [Related]
14. Extractables Screening of Polypropylene Resins Used in Pharmaceutical Packaging for Safety Hazards.
Jenke D
PDA J Pharm Sci Technol; 2017; 71(5):346-367. PubMed ID: 28512176
[TBL] [Abstract][Full Text] [Related]
15. An extractables/leachables strategy facilitated by collaboration between drug product vendors and plastic material/system suppliers.
Jenke D
PDA J Pharm Sci Technol; 2007; 61(1):17-23. PubMed ID: 17390700
[TBL] [Abstract][Full Text] [Related]
16. Essential Aspects in Assessing the Safety Impact of Interactions between a Drug Product and Its Associated Manufacturing System.
Jenke D
PDA J Pharm Sci Technol; 2012; 66(1):63-77. PubMed ID: 22307663
[TBL] [Abstract][Full Text] [Related]
17. Recommendation of Single Time Point Leachables Testing for Lyophilized Biotechnology Products Stored in Rubber Stoppered Glass Vial Systems.
Gallegos A; Liu J; Ronk M; Qi L; Li K; Semin D; Nashed-Samuel Y
J Pharm Sci; 2022 Jun; 111(6):1599-1604. PubMed ID: 35257694
[TBL] [Abstract][Full Text] [Related]
18. The Use of TOC Reconciliation as a Means of Establishing the Degree to Which Chromatographic Screening of Plastic Material Extracts for Organic Extractables Is Complete.
Jenke D; Couch TR; Robinson SJ; Volz TJ; Colton RH
PDA J Pharm Sci Technol; 2014; 68(3):256-70. PubMed ID: 25188347
[TBL] [Abstract][Full Text] [Related]
19. Extractables and leachables considerations for prefilled syringes.
Jenke DR
Expert Opin Drug Deliv; 2014 Oct; 11(10):1591-600. PubMed ID: 24955780
[TBL] [Abstract][Full Text] [Related]
20. Standardization of Chromatographic Screening Methods for Organic Extractables and Leachables by Managing Outcomes.
Jenke D
PDA J Pharm Sci Technol; 2023; 77(4):329-338. PubMed ID: 37001885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
